TSM

232.52

-2.6%↓

ORCL

255.62

+1.12%↑

ASML.US

689

-1.42%↓

IBM

250.47

-0.54%↓

NOW

904.5

-2.03%↓

TSM

232.52

-2.6%↓

ORCL

255.62

+1.12%↑

ASML.US

689

-1.42%↓

IBM

250.47

-0.54%↓

NOW

904.5

-2.03%↓

TSM

232.52

-2.6%↓

ORCL

255.62

+1.12%↑

ASML.US

689

-1.42%↓

IBM

250.47

-0.54%↓

NOW

904.5

-2.03%↓

TSM

232.52

-2.6%↓

ORCL

255.62

+1.12%↑

ASML.US

689

-1.42%↓

IBM

250.47

-0.54%↓

NOW

904.5

-2.03%↓

TSM

232.52

-2.6%↓

ORCL

255.62

+1.12%↑

ASML.US

689

-1.42%↓

IBM

250.47

-0.54%↓

NOW

904.5

-2.03%↓

Начало・Списък с акции・Sapiens International Corp NV

Sapiens International Corp NV

Затворен

26.93 -0.37

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

26.5

Максимум

27.11

Ключови измерители
By Trading Economics
Приходи	167K 18M
Продажби	1.8M 136M
P/E Средно за сектора	22.431 71.636
Дивидентна доходност	2.08
Марж на печалбата	13.25
Служители	4,850
EBITDA	-282K 26M

Препоръки
By TipRanks
Препоръки	Неутрален
12-месечна прогноза	+14.65% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	2.08% 2.51%
Следващи печалби	13.08.2025 г.
Следваща дата на дивидент	11.09.2025 г.
Следваща дата на екс-дивидент	27.08.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	54M 1.6B
Предишно отваряне	27.3
Предишно затваряне	26.93

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

27.28 / 28.82 Подкрепа & съпротива

Sapiens International Corp NV Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

4.08.2025 г., 21:42 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4.08.2025 г., 21:21 ч. UTC

Печалби

Значими двигатели на пазара

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4.08.2025 г., 20:45 ч. UTC

Печалби

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4.08.2025 г., 19:15 ч. UTC

Значими двигатели на пазара

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4.08.2025 г., 23:41 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

4.08.2025 г., 23:41 ч. UTC

Пазарно говорене

Nikkei May Rise on Fed Stimulus Hopes

4.08.2025 г., 23:28 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

4.08.2025 г., 23:28 ч. UTC

Пазарно говорене

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4.08.2025 г., 21:30 ч. UTC

Печалби

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4.08.2025 г., 21:21 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4.08.2025 г., 21:18 ч. UTC

Печалби

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4.08.2025 г., 20:25 ч. UTC

Пазарно говорене

India Hits Back Over Russian Oil Purchases -- Market Talk

4.08.2025 г., 20:25 ч. UTC

Печалби

Transocean 2Q Loss $938M >RIG

4.08.2025 г., 20:25 ч. UTC

Печалби

Transocean 2Q Loss/Shr $1.06 >RIG

4.08.2025 г., 20:18 ч. UTC

Печалби

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4.08.2025 г., 20:15 ч. UTC

Печалби

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4.08.2025 г., 20:14 ч. UTC

Печалби

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4.08.2025 г., 20:14 ч. UTC

Печалби

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4.08.2025 г., 20:14 ч. UTC

Печалби

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4.08.2025 г., 20:13 ч. UTC

Печалби

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4.08.2025 г., 20:09 ч. UTC

Печалби

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4.08.2025 г., 20:06 ч. UTC

Печалби

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4.08.2025 г., 20:01 ч. UTC

Печалби

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4.08.2025 г., 20:01 ч. UTC

Печалби

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4.08.2025 г., 20:01 ч. UTC

Печалби

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4.08.2025 г., 20:01 ч. UTC

Печалби

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4.08.2025 г., 19:41 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Settle Lower -- Market Talk

4.08.2025 г., 19:28 ч. UTC

Пазарно говорене

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4.08.2025 г., 19:07 ч. UTC

Пазарно говорене

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4.08.2025 г., 18:27 ч. UTC

Пазарно говорене

Gold Climbs on Rate Cut Speculation -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Sapiens International Corp NV Прогноза

Ценова цел

By TipRanks

14.65% нагоре

12-месечна прогноза

Среден 30.67 USD 14.65%

Висок 35 USD

Нисък 26 USD

Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за Sapiens International Corp NV през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

4 ratings

Купи

Задържане

Продай

Според 4 анализатори, дали борсови рейтинги на Sapiens International Corp NV през последните 3 месеца.

Техническа оценка

By Trading Central

27.28 / 28.82Подкрепа & съпротива

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Sapiens International Corp NV

Sapiens International Corporation N.V. provides software solutions for the insurance industry in North America, the United Kingdom, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides various solutions for property and casualty commercial and personal lines, life and pensions, and reinsurance fields. It offers IDITSuite, an AI powered, end-to-end insurance software; DigitalSuite, a cloud-native, future-proof digital engagement platform; IDITGo, a pre-configured, data-enriched insurance launch and accelerator platform solutions; consultancy services for property and casualty commercial lines; and Tia Enterprise solution for customer engagement. The company also provides CoreSuite, an end-to-end cloud and digital PAS for individual and group products across life, health, wealth, and pensions; CustomerConnect, a dynamic self-service and persona-based portal to engage with insureds; AgentConnect, a portal for agents and brokers to focus on sales enablement, customer retention, and increasing customer value; and ReinsuranceMaster, a reinsurance automation software that provides insurers full financial control and flexibility over their entire reinsurance process. The company was founded in 1982 and is headquartered in Holon, Israel.